Topics in Pulmonary MedicineChylothorax A Review of Management OptionsDhakal, Prajwal MBBS; Bastakoti, Subash MBBS; Rayamajhi, Supratik MDAuthor Information Department of Medicine, Michigan State University, East Lansing, MI Disclosure: The authors declare that they have no conflicts of interest. Address correspondence to: Prajwal Dhakal, MBBS, Department of Internal Medicine, Michigan State University, 788 Service Road, B301 Clinical Center, East Lansing, MI, 48824. E-mail: email@example.com. Clinical Pulmonary Medicine: March 2017 - Volume 24 - Issue 2 - p 66-68 doi: 10.1097/CPM.0000000000000193 Buy Metrics Abstract Chylothorax is a rare condition caused by obstruction or injury to the thoracic duct leading to accumulation of chyle in the pleural cavity. A definitive guideline for management is lacking and most cases are managed with a staged care plan that moves from the least invasive options to more invasive interventions. First-line therapy consists of treatment of underlying conditions, pleural drainage to control symptoms, and dietary modifications. Surgical measures including pleurodesis and thoracic duct ligation are pursued if conservative measures are ineffective. In recent times, percutaneous image-guided interventions such as thoracic duct embolization and thoracic duct disruption are increasingly being used. These interventions have shown promising results and are used to manage patients with failed conservative therapy, high-output chylothorax, and those who cannot tolerate surgical procedures. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.